Multi-organ system and quality-of-life benefits sustained through five years of treatment– 82% response rate for the multi-component endpoint – ...

Bones are not stagnant structures. According to recent studies, bones maintain a lively metabolism and closely interact via nerves with the brain. But whether endocrine hormones also play an important ...

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will ...

Applying a pretreatment of a parathyroid hormone, commonly used to increase bone mass to combat osteoporosis, can help improve cartilage health and slow the development of osteoarthritis, Cornell ...

Leptin a Potential Target to Reduce CVD Risk in CKD-MBD TransCon PTH is an investigational once-daily long-acting prodrug of parathyroid hormone (PTH[1-34]) designed to restore physiologic levels of ...

The researchers conducted a systematic review and meta-analysis of 12 case-control studies of patients with NAFLD/NASH and a comparison group without NAFLD/NASH. All studies had data on mean PTH ...

A pair of clinical guidelines on hypo- and hyperparathyroidism, respectively, had a coming-out party at the American Society for Bone and Mineral Research's (ASBMR) annual meeting on Sunday, allowing ...

Hypothyroidism is when the thyroid gland does not make enough thyroid hormone. Hypoparathyroidism is comparatively rare, where the parathyroid glands behind the thyroid do not produce enough ...

Hypoparathyroidism results from insufficient parathyroid hormone, leading to low blood calcium and high phosphorus levels, whereas hypothyroidism is due to an underactive thyroid gland, causing a ...

Parathyroid cancer is a very rare type of cancer, leading to fragile and painful bones, digestive trouble, and kidney stones. Less than 100 people receive a diagnosis in the United States each year.